These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2268374)

  • 1. Monoamine oxidase substrates in Parkinson's disease.
    Humfrey CD; Steventon GB; Sturman SG; Waring RH; Griffiths B; Williams AC
    Biochem Pharmacol; 1990 Dec; 40(11):2562-4. PubMed ID: 2268374
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation.
    Jarman J; Glover V; Sandler M; Turjanski N; Stern G
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):1-4. PubMed ID: 8439389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet monoamine oxidase B activity in parkinsonian patients.
    Bonuccelli U; Piccini P; Del Dotto P; Pacifici GM; Corsini GU; Muratorio A
    J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):854-5. PubMed ID: 2266365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity of human platelet monoamine oxidase B activity Parkinson's and Alzheimer's disease.
    Fitzgerald DH; Tipton KF; Anderson MC; Lawlor B
    Biochem Soc Trans; 1996 Feb; 24(1):63S. PubMed ID: 8674739
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet MAO activities and MAO-B protein concentrations in Parkinson's disease and controls.
    Finch CC; Ho SL; Williams AC; Billett EE
    Prog Brain Res; 1995; 106():85-90. PubMed ID: 8584677
    [No Abstract]   [Full Text] [Related]  

  • 6. MAO-B and Parkinson's disease.
    Sturman SG; Steventon GB; Waring RH; Williams AC
    Mov Disord; 1990; 5(4):338-9. PubMed ID: 2259360
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patients.
    Kuiper MA; Konings CH; Bergmans PL; Wolters EC
    J Neurol Sci; 1993 Jul; 117(1-2):41-5. PubMed ID: 8410065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?
    Sandler M; Glover V; Clow A; Jarman J
    Adv Neurol; 1993; 60():238-41. PubMed ID: 8420141
    [No Abstract]   [Full Text] [Related]  

  • 9. Ageing, monoamines, and monoamine-oxidase levels.
    Robinson DS; Nies A; Davis JN; Bunney WE; Davis JM; Colburn RW; Bourne HR; Shaw DM; Coppen AJ
    Lancet; 1972 Feb; 1(7745):290-1. PubMed ID: 4109932
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase B and Parkinson's disease.
    Steventon G; Humfrey C; Sturman S; Waring RH; Williams AC
    Lancet; 1990 Jan; 335(8682):180. PubMed ID: 1967482
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine oxidase, brain ageing and degenerative diseases.
    Strolin Benedetti M; Dostert P
    Biochem Pharmacol; 1989 Feb; 38(4):555-61. PubMed ID: 2521790
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet monoamine oxidase-B activity in Parkinson's disease.
    Steventon GB; Sturman SG; Heafield MT; Waring RH; Napier J; Williams AC
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):255-61. PubMed ID: 2597311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein content and monoamine oxidase activity in platelets.
    Zeller EA; Davis JM
    Schizophr Bull; 1980; 6(2):267-74. PubMed ID: 7375859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson's disease.
    Müller T; Riederer P; Grünblatt E
    J Neural Transm (Vienna); 2017 Jun; 124(6):745-748. PubMed ID: 28299453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet monoamine oxidase in an aged general population and elderly chronic schizophrenics [[proceedings].
    Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ
    Psychopharmacol Bull; 1981 Jan; 17(1):103-4. PubMed ID: 7232634
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered redox state of platelet coenzyme Q10 in Parkinson's disease.
    Götz ME; Gerstner A; Harth R; Dirr A; Janetzky B; Kuhn W; Riederer P; Gerlach M
    J Neural Transm (Vienna); 2000; 107(1):41-8. PubMed ID: 10809402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet monoamine oxidase activity in schizophrenia.
    White HL; McLeod MN; Davidson JR
    Am J Psychiatry; 1976 Oct; 133(10):1191-3. PubMed ID: 970490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelet monoamine oxidase activity in glaucoma.
    Aldinio C; Cerletti C; Manara L; Recchia M; Carlevaro G; de Molfetta V
    Invest Ophthalmol Vis Sci; 1979 Mar; 18(3):320-4. PubMed ID: 422336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An allelic association study of monoamine oxidase B in Parkinson's disease.
    Ho SL; Kapadi AL; Ramsden DB; Williams AC
    Ann Neurol; 1995 Mar; 37(3):403-5. PubMed ID: 7695241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of monoamine oxidase.
    Tipton KF
    Methods Find Exp Clin Pharmacol; 1985 Jul; 7(7):361-7. PubMed ID: 4058103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.